Skip to content

Clinical trials

Phase 2 Hereditary Sensory and Autonomic Neuropathies trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hereditary Sensory and Autonomic Neuropathies Phase: Phase 2 Country / region: Germany Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20171
20181
20201
20211
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AllRock Bio, Inc.1
Bristol-Myers Squibb1
EMD Serono Research & Development Institute, Inc.1
Incyte Corporation1
Novartis Pharmaceuticals1
Pfizer1
Revolution Medicines, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hereditary Sensory and Autonomic Neuropathies7
Breast Neoplasms1
Bronchial Neoplasms1
Campomelic Dysplasia1
Carcinoma1
Carcinoma, Non-Small-Cell Lung1
Cardiomyopathy, Dilated1
Distal Myopathies1
Hypertension, Pulmonary1
Lung Diseases1

Trials

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.